Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026
Key Highlights
- ➤Kamada CEO Amir London to present at Stifel Healthcare Conference November 10, 2026
- ➤London available for investor meetings at Stifel and Jefferies conferences
- ➤Jefferies Global Healthcare Conference participation scheduled for November 16-19, 2026
- ➤Kamada owns three FDA-approved plasma collection centers in Texas
REHOVOT, Israel and HOBOKEN, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Amir London, Chief Executive Officer, will participate in two investor conferences during the month of November.
Mr. London will attend the Stifel 2026 Healthcare Conference, to be held at the Lotte New York Palace Hotel, New York, NY on November 10-12, 2026, and is scheduled to present at 10:00 a.m. Eastern Time on Tuesday, November 10, 2026. In addition to the presentation, Mr. London will be available for one-on-one investor meetings throughout the conference. Investors interested in arranging a meeting should contact their Stifel representative.
Get started
Create a free account to read the full story.